Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
23 May 2024
Historique:
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 23 5 2024
Statut: aheadofprint

Résumé

Bacterial infections create distinctive microenvironments with a unique mix of metabolites and enzymes compared with healthy tissues that can be used to trigger the activation of antibiotic prodrugs. Here, a single and dual prodrug masking the C3 carboxylate and C7 piperazine of the fluoroquinolone, ciprofloxacin, responsive to nitroreductase (NTR) and/or hydrogen sulfide (H

Identifiants

pubmed: 38780408
doi: 10.1021/acs.jmedchem.4c00724
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Catherine L Ross (CL)

School of Pharmacy, University of Otago, Dunedin 9054, New Zealand.
Department of Microbiology and Immunology, University of Otago, Dunedin 9054, New Zealand.

Aggie Lawer (A)

School of Pharmacy, University of Otago, Dunedin 9054, New Zealand.

Kathleen J Sircombe (KJ)

School of Pharmacy, University of Otago, Dunedin 9054, New Zealand.
Department of Microbiology and Immunology, University of Otago, Dunedin 9054, New Zealand.

Daniel Pletzer (D)

Department of Microbiology and Immunology, University of Otago, Dunedin 9054, New Zealand.

Allan B Gamble (AB)

School of Pharmacy, University of Otago, Dunedin 9054, New Zealand.

Sarah Hook (S)

School of Pharmacy, University of Otago, Dunedin 9054, New Zealand.

Classifications MeSH